MedVellum
MedVellum
Back to Library
Emergency Medicine
Cardiology
Intensive Care
Anaesthetics
EMERGENCY

Cardiac Arrest & Resuscitation in Adults

High EvidenceUpdated: 2024-12-21

On This Page

Red Flags

  • Unresponsive with no normal breathing
  • Agonal or gasping breaths
  • Absent carotid pulse
  • VF or pVT on monitor
  • Asystole or PEA
  • Witnessed collapse
Overview

Cardiac Arrest & Resuscitation in Adults

Clinical Overview

Summary

Cardiac arrest is the cessation of effective cardiac mechanical activity. Survival depends on early recognition, early CPR, early defibrillation (for shockable rhythms), and high-quality post-resuscitation care. The 2021 Resuscitation Council UK guidelines emphasise high-quality CPR (rate 100-120/min, depth 5-6cm), minimising interruptions, and treating reversible causes (4 Hs and 4 Ts).

Key Facts

  • Incidence: ~30,000 OHCA and ~28,000 IHCA per year in UK
  • Survival to discharge: OHCA 8-10%; IHCA 15-25%
  • VF/pVT survival: 25-35% with early defibrillation
  • Each minute without CPR: 7-10% decrease in survival
  • Bystander CPR: Doubles survival rates

Clinical Pearls

Push hard, push fast: Rate 100-120/min, depth 5-6cm, full chest recoil

Defibrillation within 3-5 minutes of VF/pVT gives best outcomes

After each 2-minute cycle: rhythm check, pulse check if organised rhythm, and consider reversible causes

Why This Matters Clinically

Cardiac arrest is the ultimate medical emergency. The quality of resuscitation directly impacts survival and neurological outcome. All healthcare professionals must be competent in BLS and understand ALS principles.


2. Epidemiology

Incidence & Prevalence

  • OHCA incidence: ~55 per 100,000 population/year
  • IHCA incidence: ~1.5 per 1,000 hospital admissions
  • VF/pVT as initial rhythm: 25% OHCA, 20% IHCA
  • PEA/Asystole: More common initial rhythms (60-70%)

Demographics

  • Age: Incidence increases exponentially over 65 years
  • Sex: Male:female 3:1 for OHCA
  • Underlying conditions: CAD 70%, cardiomyopathy 10%, channelopathies 5%

Risk Factors

CategoryExamples
CardiacPrevious MI, heart failure, arrhythmias
DrugsQT-prolonging medications, cocaine, digoxin
MetabolicHypokalaemia, hyperkalaemia, hypomagnesaemia
EnvironmentalDrowning, electrocution, hypothermia

Pathophysiology

Overview

Cardiac arrest results from cessation of coordinated electrical activity or mechanical failure despite electrical activity. The resulting global ischaemia causes cellular injury within minutes.

Arrest Rhythms

RhythmMechanismTreatment
VFChaotic ventricular depolarisationDefibrillation
Pulseless VTOrganised fast ventricular rhythm without outputDefibrillation
PEAElectrical activity without mechanical outputCPR + treat cause
AsystoleNo electrical or mechanical activityCPR + treat cause

The 4 Hs and 4 Ts

Reversible Causes:

4 Hs4 Ts
HypoxiaTension pneumothorax
HypovolaemiaTamponade (cardiac)
Hypo/HyperkalaemiaToxins
HypothermiaThrombosis (coronary/pulmonary)

Classification

By Initial Rhythm

Rhythm TypeCategoryApproach
VF/pVTShockableImmediate defibrillation
PEANon-shockableCPR + reversible causes
AsystoleNon-shockableCPR + reversible causes

By Location

  • OHCA: Out-of-hospital cardiac arrest
  • IHCA: In-hospital cardiac arrest

By Cause

  • Cardiac: Ischaemic, arrhythmic, structural
  • Non-cardiac: Hypoxia, trauma, overdose, drowning

Investigations

During Resuscitation

  • Rhythm monitoring: Identify shockable vs non-shockable
  • End-tidal CO2: Confirms ventilation, indicator of ROSC (rise suggests ROSC)
  • ABG/VBG: pH, lactate, K+, glucose
  • Bedside echo: Cardiac activity, tamponade, RV dilation (PE)
  • Point-of-care glucose: Hypoglycaemia as cause

Post-ROSC

  • 12-lead ECG: ST changes, arrhythmias
  • CXR: ETT position, pulmonary oedema, pneumothorax
  • Bloods: Troponin, U&Es, FBC, coagulation, lactate trend
  • CT head: If no clear cardiac cause
  • CT coronary angiography: If STEMI or suspected coronary cause
  • Echocardiography: LV function, structural abnormalities

Management

Immediate Management: ALS Algorithm

Shockable Rhythm (VF/pVT):

  1. Defibrillation 150-360J biphasic
  2. Resume CPR immediately for 2 minutes
  3. Check rhythm after 2-minute cycle
  4. Adrenaline 1mg IV after 3rd shock, then every 3-5 minutes
  5. Amiodarone 300mg IV after 3rd shock
  6. Consider further amiodarone 150mg after 5th shock

Non-Shockable Rhythm (PEA/Asystole):

  1. CPR for 2 minutes
  2. Adrenaline 1mg IV as soon as IV access, then every 3-5 minutes
  3. Check rhythm after 2-minute cycle
  4. Identify and treat reversible causes

CPR Quality

  • Rate: 100-120 compressions/minute
  • Depth: 5-6 cm in adults
  • Recoil: Complete chest recoil between compressions
  • Minimise interruptions: Fraction over 80%

Post-ROSC Care

  1. Airway: Secure if not already
  2. Oxygenation: Target SpO2 94-98%
  3. Ventilation: Target normocapnia (PaCO2 4.5-6.0 kPa)
  4. Blood pressure: MAP over 65 mmHg
  5. Temperature: Targeted temperature management 32-36°C
  6. Coronary angiography: If STEMI or likely cardiac cause
  7. ICU admission: Neuroprognostication after 72 hours

Complications

During Resuscitation

  • Rib fractures (common, not a reason to stop)
  • Pneumothorax
  • Aspiration
  • Failed intubation

Post-ROSC

ComplicationIncidenceManagement
Hypoxic brain injury60-70%TTM, neuroprognostication
Myocardial stunningCommonInotropes, IABP
Aspiration pneumonia30%Antibiotics if confirmed
DIC10-15%Supportive

Prognosis

Survival Rates

  • OHCA survival to discharge: 8-10%
  • IHCA survival to discharge: 15-25%
  • VF/pVT with early defibrillation: 30-40%
  • Good neurological outcome (CPC 1-2): 70% of survivors

Prognostic Factors

FavourableUnfavourable
Witnessed arrestUnwitnessed
Early bystander CPRNo bystander CPR
VF/pVT rhythmAsystole
Short no-flow timeProlonged arrest
ROSC under 20 minutesROSC over 30 minutes

Neuroprognostication

  • Performed ≥72 hours post-ROSC
  • Multimodal approach: clinical exam, EEG, somatosensory evoked potentials, CT/MRI

Key Evidence

Landmark Studies

TTM Trial (2013) PMID: 24237006

  • No difference between 33°C vs 36°C target temperature
  • Both groups had good outcomes compared to historical controls

TTM2 Trial (2021) PMID: 34133859

  • 33°C vs normothermia (under 37.8°C)
  • No benefit of hypothermia over targeted normothermia

PARAMEDIC2 Trial (2018) PMID: 30012709

  • Adrenaline vs placebo in OHCA
  • Improved overall survival but not neurologically favourable survival

Guidelines

  • Resuscitation Council UK Guidelines 2021
  • European Resuscitation Council Guidelines 2021
  • AHA Guidelines 2020

Patient & Family Information

What is Cardiac Arrest?

Cardiac arrest is when the heart suddenly stops pumping blood around the body. This is different from a heart attack (where blood supply to the heart is blocked). Without immediate treatment, it is fatal within minutes.

What to Expect

  • Your loved one needed emergency resuscitation
  • They will be in intensive care for monitoring
  • Cooling treatment may be used to protect the brain
  • Doctors will assess brain function after at least 72 hours
  • The team will keep you updated regularly

Recovery

  • Some people make a full recovery
  • Others may have memory or cognitive difficulties
  • Cardiac rehabilitation is available for survivors
  • Support groups exist for survivors and families

Resources

  • Resuscitation Council UK
  • Sudden Cardiac Arrest UK
  • British Heart Foundation

Last updated: 2024-12-21

At a Glance

EvidenceHigh
Last Updated2024-12-21
Emergency Protocol

Red Flags

  • Unresponsive with no normal breathing
  • Agonal or gasping breaths
  • Absent carotid pulse
  • VF or pVT on monitor
  • Asystole or PEA
  • Witnessed collapse

Clinical Pearls

  • **Push hard, push fast**: Rate 100-120/min, depth 5-6cm, full chest recoil
  • Defibrillation within 3-5 minutes of VF/pVT gives best outcomes
  • After each 2-minute cycle: rhythm check, pulse check if organised rhythm, and consider reversible causes

Guidelines

  • NICE Guidelines
  • BTS Guidelines
  • RCUK Guidelines